Linda Johnson

I Stock 1092645806

Best Practices for Manufacturing Industry Channel Sales Incentive Programs

November 29, 2022

Oculus Founder Builds Fatal Feature into VR Headset

November 9, 2022

Caterpillar Settles Federal Tax Dispute

September 14, 2022

A man shops at a supermarket in New York, July 27, 2022.

Key Inflation Gauge Reaches 6.8% as Prices Keep Surging

July 29, 2022

Industrial Media Unboxing Video

Industrial Media Unboxing Video

IEN Unboxed is a new show in which our editors unbox new tools on the market and discuss their features.

November 23, 2022

In this file photo, a pharmacist holds a vial of the Johnson & Johnson COVID-19 vaccine.

FDA Found Problems at J&J Vaccine Factory

The issues ranged from poorly trained employees to cracked vials to mold around one of its facilities.

April 21, 2021

President Joe Biden speaks about efforts to combat COVID-19, in the State Dining Room of the White House, Tuesday, March 2, 2021, in Washington.

Biden Vows Enough Vaccine for All US Adults by End of May

Biden’s announcements quickly raised expectations for when the nation could safely emerge from the pandemic.

March 3, 2021

Mike McDermott, president of global supply since 2019.

Insider Q&A: Pfizer Exec on Ramping Up Vaccine Supply

"We look at reducing wait times when changing over between batches, doubling of our batch size, increasing yields per batch."

February 15, 2021

This Sept. 2020 photo provided by Johnson & Johnson shows a clinician preparing to administer investigational Janssen COVID-19 vaccine.

J&J 1-Dose Shot Works, Less Effective Than Others

It appears to protect against COVID-19, but not as strongly as some two-shot rivals.

January 29, 2021

In this Nov. 9, 2020, file photo, pedestrians walk past Pfizer world headquarters in New York. Pfizer announced Wednesday, Nov. 18, 2020, more results in its ongoing coronavirus vaccine study that suggest the shots are 95% effective a month after the first dose.

Pfizer: COVID-19 Shot 95% Effective, Seeking Clearance Soon

New data suggests the vaccine works even better than Pfizer initially reported.

November 18, 2020

I Stock 1154450279

Pfizer Says COVID-19 Vaccine Looks 90% Effective

The data would put the company on track to apply for emergency-use approval from the FDA.

November 9, 2020

A single-dose COVID-19 vaccine being developed by Johnson & Johnson.

Late-Stage Study of First Single-Shot Vaccine Begins in US

U.S. health officials insist the race for a vaccine isn't cutting corners.

September 23, 2020